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A B S R A C T
We report the presence of Chikungunya (CHIKV) RNA in the blood, urine and semen during the acute
phase of the disease in an adult with a dual infection with Dengue virus type 3. The patient, a 25 yr-old
man from Salvador, Brazil, reported a 6-day duration of high fever, arthralgia, myalgia, headache and
photophobia.
Blood and semen specimens were positive for CHIKV in the ﬁrst collected samples; semen and urine
specimens were positive for CHIKV after 30 days of symptoms onset. DENV-3 RNA was positive in blood
specimen when ﬁrst collected 6 days after the initiation of symptoms.We describe for the ﬁrst time the
presence of CHIKV RNA in urine and semen for an extended period of time and we address the possible
implications of these ﬁndings for diagnosis and transmission dynamics.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Zika and Chikungunya viruses are both transmitted by Aedes
aegypti mosquitoes and are associated with an abrupt onset of
fever, arthralgia, myalgia and rash [1]. In Brazil, acute exanthema-
tous outbreaks related to Zika (ZIKV) and Chikungunya viruses
(CHIKV) have been reported in many regions and sometimes as co-
infections [2–5].
Acute Chikungunya infection generally leads to prominent joint
symptoms with moderate to severe arthralgia and arthritis that* Corresponding author.
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other neurological involvements may also complicate CHKV
infection such as recently reported a neonatal encephalitis in
Brazil with similar lesions on brain scan as those previously
described in the La Réunion Islands [7–9]. In all these situations, a
rapid diagnosis is of importance for epidemiological purposes and
clinical management.
In ZIKV infections, the molecular diagnosis in serum is generally
possible until the ﬁrst six days of symptoms onset and, later on, urine
or saliva is used [10,11]. Zika detection in urine may help in
ascertaining the diagnosis after the initial period of viremia in areas
with co-circulation of ZIKV and Dengue virus (DENV), where
serologic cross-reactions may occur, but evidence for that associated
with CHIKV infection has not been shown [12]. An expandedwindow
for diagnosis in CHIKV is also needed since IgM seropositivity may
persist formonthsafterthe initialacute infection.Manyotherviruses
have been detected in semen, such as Ebola, HIV, HBV, HPV, HSV-1,der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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presence of CHIKV in semen [13–17].
We report the presence of CHIKV RNA for a prolonged period of
time in the urine and semen of an adult with a dual infection with
Dengue virus type 3 for a prolonged period of time.
Case
A 25-year-old man from Salvador, Brazil presented with a 6 days
of high fever, arthralgia, myalgia, headache and photophobia. He
also reported a burning sensation on his eyes and a non-pruritic
rash in the trunk and upper limbs on the ﬁrst 3 days, and
complained of pain involving the ankles, knees, shoulders, wrists,
lower back, and neck. Of note, he also reported a transient burning
sensation in the urethra and genital region that started 3 days
before the onset of symptoms and resolved spontaneously. On
examination the patient was febrile with a temperature of 38.3C,
had a maculopapular erythematous diffuse rash, joint enlargement
with mild inﬂammatory signs affecting the wrists, the metacar-
pophalangeal and metatarsophalangeal joints as well as the ankles.
The patient was not able to raise his arms on command because of
shoulder pain and was eating with difﬁculty because of pain
involving his temporomandibular joint.
Blood samples were drawn for viral workup, semen was also
requested due to the complaint of dysuria, and the possibility for
Zika diagnosis since the patient could not provide a urine sample at
that time. Blood, urine and semen were collected again after
30 days of symptoms onset and were further processed. Serum and
semen samples were submitted to viral RNA extraction using a
Maxwell Total Viral Nucleic Acid 16 Purication Kit (Promega, USA)
regarding that the semen sample, the incubation time of the lysis
step was extended to 30 min. Urine sample was submitted to viral
RNA extraction using QiAmp viral RNA puriﬁcation (Qiagen, USA).
Subsequent to viral RNA extraction, all samples were submitted to
RT–PCR technique (AccessQuickTM System, Promega, USA) to
screen for CHIKV, ZIKV and DENV using conventional techniques
[18–20].
Serum and semen specimens were positive for CHIKV RNA in
the ﬁrst collected samples; semen and urine specimens were
positive for CHIKV RNA after 30 days of symptoms onset, with
negative results in serum. DENV-3 RNA was positive in serum
specimen when ﬁrst collected 6 days after the initiation of
symptoms and was not tested thereafter. All specimens tested
negative for ZIKV.
Table 1 presents the clinical ﬁndings and molecular results
during the time frame of infection. The patient made use of
prednisone starting on the 2nd day of symptoms onset with 40 mgTable 1
Molecular markers and clinical course during acute dual infection with DENV-3 and CH
Time from symptoms
onset (days)a
Symptoms DENV (serum) CHIKV (serum) CH
3 Urethral burning ndb nd nd
0– +6 Fever
Arthralgia
Headache
Burning eyes
Rash
Pos+ Pos+ nd
+30 Resolved nd Neg– Po
Pos+ means a positive result.
Neg means a negative result.
a A negative sign preceding a numeral meaning the number of days before initiation
b not done.QD for 10 days, tapering to 20 mg QD for the next 10 days, and
10 mg QD for the last 8 days, with an uneventful course and no
clinical ﬁndings after 30 days.
Discussion
Many different viruses can be isolated in semen specimens for
prolonged periods of time. Ebola RNA (EBO-RNA) can be detected
in up to 290 days after clinical manifestations and Ebola infectious
particles in up to 70 days [21]. Transmission of Ebola virus (EBOV)
from a male survivor to a female has been documented 179 days
after illness in Liberia [21]. In another study, persistence of EBO-
RNA could be found in semen specimens at least 9 months after the
onset of symptoms with important consequences related to sexual
transmission [16]. Many papers have reinforced the sexual
transmission of ZIKV since Foy et al. have suggested its relationship
[22–25]. This report, besides describing a patient with classical
signs of ZIKV, drew attention to symptoms of prostatitis with
hematospermia [25]. Our patient reported a burning sensation in
the urethra and the genital region and may also have had a
transient prostatic involvement with detection of CHIKV RNA in
semen. ZIKA RNA has been detected in semen for up to 6 months
after the onset of symptoms and is involved in male-to-female as
well as in female-to-male transmission [26,27].
The precise replication site for many of the viruses found in
semen is unknown. Luttmer et al. studying Human Papilloma virus
(HPV) have found a high prevalence of this virus in semen – 27.2%
of healthy adults in Amsterdam – and using ﬂuorescence in situ
hybridization (FISH) for HPV-DNA and immunocytochemistry for
the HPV-L1 and HPV-E4 proteins, the authors detected HPV-DNA,
HPV-E4 and HPV-L1 in exfoliated keratinocytes present in some
HPV16-positive semen samples, indicating the presence of HPV
viral particles [28].
Even though Alphavirus envelope glycoproteins function as the
attachment point to cells, no human cell surface receptor has been
implicated in cell entry so far.
Primary peripheral blood cells such as CD4+ T lymphocytes,
primary CD14+ monocytes and dendritic cells were reported to be
refractory to CHIKV binding and infection [29]. Macrophages, on
the other hand, are highly sensitive to CHIKV and showed
cytopathic effect following CHIKV infection [29,30]. Mononuclear
cell inﬁltration and viral replication in the muscles (particularly
skeletal muscle progenitor cells, not muscle ﬁbers) and joints are
associated with myalgia and arthralgia and synovial macrophages
have been shown to contain viral RNA months after infection [31].
It may be postulated that an inﬂammatory inﬁltration with
macrophages in the genital tract may be the source of the CHIKV,IKV.
IKV (urine) CHIKV (semen) ZIKV (serum) ZIKV (urine) ZIKV (semen)
 nd nd nd nd
 Pos+ Neg– Neg– Neg–
s+ Pos+ Neg– Neg– Neg–
 of CHIKV/DENV symptoms.
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semen. The detection of CHIKV in semen has many important
implications, including the possibility of sexual transmission. Even
though we did not perform cytopathic assays for CHIKV, this
ﬁnding must be further investigated. We did not ﬁnd any other
study showing evidence of CHIKV in semen and, specially, for such
a long period since the onset of symptoms.
Another unique ﬁnding in our study was the detection of CHIKV
in urine after 30 days of the initial symptoms contrasting with
recent ﬁndings in literature showing no detection of CHIKV in
urine after the ﬁrst week of symptoms onset [32]. This could
provide an expanded window for the diagnosis of a recent
infection with CHIKV. The use of prednisolone may have
contributed to the prolonged viral shedding and another factor
that may, in part, have added to that was the possible interaction
between Chikungunya and Dengue type 3. With the ongoing
circulation of DENV, CHIKV and ZIKV in Brazil, such a ﬁnding of
dual infections will be increasingly seen and reported, as we
recently published for CHIKV and ZIKV [5]. In India, an estimate of
co-infection with CHIKV and DENV using serological markers
estimated point prevalences on the range of 5.7–9.5% [33]. In
1964 Myers and Carey reported that seven patients out of
332 patients (2.1%) from south India had a simultaneous increase
in antibody to both CHIKV and DENV virus and that these patients
had also an unremarkable clinical course and an expected
development of antibodies to both agents, indicating that the
host response was not altered by the dual infection [34]. During an
outbreak of both CHIKV and DENV-1 in Toamasina, Madagascar, in
2006, 10 out of 55 patients sampled (18.2%) were shown to be co-
infected with both virus with no complications recorded [35].
However, Chahar et al. reported that during the 2006 dengue
outbreak in Delhi six patients were co-infected with CHIKV and
DENV (with DENV-3 in 5 out of 6), 2 of these patients had dengue
hemorrhagic fever with central nervous system (CNS) involvement
and one patient died [36]. More recently, Villamil-Gomez et al.
reported a 49-year-old male from Colombia with a febrile illness,
bilateral conjunctivitis and a pruritic rash that was diagnosed with
ZIKV, CHIKV and DENV and had an uneventful course [37]. The true
extent of CHIKV-DENV co-infection has been hampered by current
diagnosis largely based on clinical grounds with unavailability of
molecular methods in many parts of the world [38,39].
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